In FDA’s latest approval of a new medication to treat multiple myeloma, the agency approved Ninlaro capsules, the first and only oral proteasome inhibitor, indicated in combination with lenalidomide and dexamethasone for the treatment of patients with multiple myeloma who have received at least one prior therapy
Physicians in ACOs believe pharma companies could help reduce the cost of healthcare—but suspect they won’t
Healthcare providers believe that the pharmaceutical industry could play an important role in helping value-based healthcare providers such as accountable care organizations to deliver better care at lower cost. But pharma companies currently do a poor job of delivering the kind of data needed to accomplish that goal, according to a survey of physicians in value-based delivery models, conducted by Oliver Wyman, a New York-based management consulting firm.
Recent reports of Medicare Part D beneficiaries who have been caught in the doughnut hole have related how some have cut back on medications.
While Hurricane Katrina has disrupted healthcare for millions of people, one beneficial outcome may be more public and private efforts to develop a national electronic health records (EHR) system.
USP has been awarded a cooperative agreement with the Centers for Medicare and Medicaid Services (CMS) to revise the Part D Prescription Drug Benefit Model Guidelines.
Bethesda, Md.-The daily activities of health-system pharmacists are greatly
affected by the Health Insurance Portability and Accountability Act of 1996
(HIPAA). To help keep practitioners up-to-date with current regulations
and other important information, ASHP has developed an online resource center
on its website, www.ashp.org.